Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 4
2000 6
2001 11
2002 8
2003 6
2004 6
2005 5
2006 8
2007 7
2008 6
2009 9
2010 9
2011 7
2012 4
2013 8
2014 7
2015 7
2016 5
2017 6
2018 5
2019 5
2020 9
2021 9
2022 11
2023 5
2024 7
2025 5
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175 results

Results by year

Filters applied: . Clear all
Page 1
Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Mutant NSCLC Across Treatment Lines: Evidence From the TRACER/HERTras Real-World Cohort.
Illini O, Hund AC, Kopp HG, Moskovitz M, Mountzios G, Brueckl WM, Früh M, Leßmann ME, Christopoulos P, Stenzinger A, Thomas M, Gillis R, Peled N, Acker F, Addeo A, Charpidou A, Grohé C, Hummel HD, Mauti L, Rothschild SI, Schmid S, Schumann C, Urban D, Wurm R, Ekman S, Skribek M, Glanemann F, Wiesweg M, Ackermann CJ, Agelaki S, Hoffknecht P, Jakopović M, Kern J, König D, Kostenzer K, Kropf-Sanchen C, Laack E, Lang D, Nagl L, Pall G, Reck M, Kian W, Allemann AT, Alt J, Araújo D, Bohnenberger H, Bokas A, Fabikan H, Julie KJ, Weinlinger C, Johannes de Langen A, Fergadis EG, Fischer R, Fountzilas E, Froesch P, Frost N, Griesinger F, Jordan F, Karanikiotis C, Kiesewetter B, Korantzis I, Machado AL, Economopoulou P, Pilz A, Reimann P, Rittmeyer A, Saad A, Samitas K, Schulmann K, Shah R, Stratmann JA, Taghizadeh H, Tammoscheit K, Tufman A, Weber JP, Wöll E, Valipour A, Overbeck TR, Hochmair MJ. Illini O, et al. Among authors: agelaki s. J Thorac Oncol. 2026 Jul;21(7):103651. doi: 10.1016/j.jtho.2026.103651. Epub 2026 Feb 24. J Thorac Oncol. 2026. PMID: 41747890 Free article.
Dermatologic adverse events associated with amivantamab: A multicentre study.
Nikolaou V, Mayor A, Sibaud V, Giacchero D, Fattore D, Apalla Z, Sollena P, Starace M, Segura S, Nosrati A, Torre AC, Riganti J, Grassi P, Tomasini P, Koumaki D, Ducharme O, Boujnah R, Koumprentziotis IA, Rapparini L, Kraehenbuehl L, Freites-Martinez A, Gaudy-Marqueste C, Oikonomou C, Grafanaki K, Agelaki S, Radevic T, Charpidou A, Peris K, Lazaridou E, Stratigos A, Malissen N. Nikolaou V, et al. Among authors: agelaki s. J Eur Acad Dermatol Venereol. 2026 Aug;40(8):e692-e695. doi: 10.1111/jdv.70360. Epub 2026 Feb 11. J Eur Acad Dermatol Venereol. 2026. PMID: 41669860 Free PMC article. No abstract available.
May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment?
Psilopatis I, Karniadakis I, Danos KS, Vrettou K, Michaelidou K, Mavridis K, Agelaki S, Theocharis S. Psilopatis I, et al. Among authors: agelaki s. Int J Mol Sci. 2022 Dec 21;24(1):93. doi: 10.3390/ijms24010093. Int J Mol Sci. 2022. PMID: 36613532 Free PMC article. Review.
175 results